Perimenopause and Anxiety Disorders: When They Happen at the Same Time
How perimenopause worsens pre-existing anxiety disorders. Treatment approaches combining therapy, HRT, and medication with practical self-management strategies.
How Perimenopause Worsens Existing Anxiety
For women with a pre-existing anxiety disorder, the perimenopausal transition can feel like a dismantling of hard-won stability. Anxiety disorders that were previously well-managed, sometimes through years of therapy and medication, may begin to resurface or intensify in ways that feel disproportionate to current life circumstances. This is not a personal failure or a sign that previous treatment did not work. It reflects the neurological reality of what fluctuating oestrogen does to the brain. Oestrogen modulates the serotonin and GABA systems, both of which are central to mood and anxiety regulation. As oestrogen becomes erratic during perimenopause, these neurotransmitter systems become less stable, lowering the anxiety threshold. Physical perimenopausal symptoms such as heart palpitations, hot flashes, and night sweats can also be interpreted by an already-sensitised nervous system as threat signals, triggering anxious thought patterns even in the absence of an identifiable stressor. Understanding that the biology is driving the anxiety, not weakness or relapse, is an important reframe.
Distinguishing Perimenopausal Anxiety from Pre-Existing Anxiety Disorder
The clinical picture when perimenopause overlaps with an anxiety disorder is genuinely complex. New or worsening anxiety during this transition might represent a hormonally driven emergence that will respond primarily to HRT. It might represent a genuine relapse of your anxiety disorder that needs psychological or pharmacological treatment. Or, most commonly, it represents both happening simultaneously, with each amplifying the other. Some distinguishing features can help clarify the picture. Anxiety that appears to track your cycle, worsening in the week before your period or during the week of ovulation, suggests a strong hormonal contribution. Anxiety that is diffuse, present most of the time regardless of cycle phase, and accompanied by the classical cognitive patterns of your particular anxiety disorder (such as worry, avoidance, or panic) suggests the anxiety disorder is active. In practice, treating both the hormonal component and the psychological component in parallel tends to produce the best outcomes rather than waiting to treat one before starting the other.
The Case for HRT in Perimenopausal Anxiety
HRT is not a first-line treatment for anxiety disorders, and it should not be used in place of evidence-based psychological or pharmacological anxiety treatments. However, for women in perimenopause who have anxiety, HRT can be a significant adjunct treatment that improves the neurochemical environment in which other treatments operate. By stabilising oestrogen levels, HRT reduces the hormonal volatility that sensitises the nervous system. Many women report that their anxiety becomes more tractable, their antidepressant or anxiolytic medication works better, and their therapy is more productive after beginning HRT. Sleep improvement through HRT also reduces anxiety: poor sleep is one of the most powerful anxiety-amplifying factors, and if night sweats are disrupting your sleep, addressing them directly improves your daytime psychological resilience. If you are currently seeing a psychiatrist or psychologist for anxiety, it is worth raising perimenopause as a potential contributing factor and asking whether a menopause specialist assessment would be helpful.
Therapy Approaches That Work During Perimenopause
Cognitive behavioural therapy remains the most evidence-based psychological treatment for anxiety disorders across the lifespan, and its effectiveness does not diminish during perimenopause. If you received CBT previously and found it helpful, a refresher course with a therapist who understands the perimenopausal context can help you reapply skills to the specific patterns that have emerged. Acceptance and commitment therapy (ACT) is particularly well-suited to perimenopausal anxiety because it emphasises flexible responding to difficult thoughts and physical sensations rather than trying to eliminate them, which can be liberating when the body is producing sensations that are genuinely difficult to ignore. Mindfulness-based cognitive therapy (MBCT) reduces anxiety through regular mindfulness practice and has particular evidence in preventing relapse of depression and anxiety. Some women benefit from somatic approaches that directly address the body-based components of anxiety, such as somatic experiencing or EMDR for those with a trauma history. Whichever approach you choose, regular rather than sporadic sessions produce better outcomes.
Medication Considerations During Perimenopause
If you are already taking an SSRI or SNRI for an anxiety disorder, perimenopause may require a review of whether your current dose remains adequate. As discussed, hormonal changes can reduce the neurochemical stability that these medications help maintain, and some women benefit from a temporary or permanent dose adjustment during this transition. This should be discussed with a prescribing doctor or psychiatrist, not managed independently by stopping or increasing medication unilaterally. If you are not currently on medication but are experiencing significant anxiety that is impacting your function, SSRIs and SNRIs are evidence-based options. SNRIs in particular, such as venlafaxine and duloxetine, have a dual benefit: they reduce anxiety and also have evidence for reducing hot flashes, which makes them a logical choice when both symptoms are present and HRT is either not wanted or not suitable. Benzodiazepines are not recommended as long-term anxiety management at any life stage due to dependence risk, though short-term use for acute severe symptoms may occasionally be appropriate under close medical supervision.
Self-Management Strategies for Daily Anxiety
Alongside formal treatment, daily self-management practices build resilience against anxiety during perimenopause. Regular aerobic exercise is one of the most robust non-pharmacological anxiolytics available. It reduces cortisol, increases GABA activity, promotes neuroplasticity, and improves sleep quality. Even 20 to 30 minutes of moderate-intensity movement daily produces measurable anxiety-reducing effects. Sleep is a non-negotiable foundation: chronic sleep disruption amplifies anxiety dramatically, so addressing night sweats, establishing a consistent sleep routine, and limiting screen exposure before bed are genuinely therapeutic decisions. Breathwork is accessible and rapidly effective for acute anxiety. Slow, diaphragmatic breathing activates the parasympathetic nervous system and counteracts the physiological anxiety response within minutes. Practices such as box breathing or 4-7-8 breathing can be used in the moment when anxiety escalates. Caffeine and alcohol both worsen anxiety in the medium term, even though alcohol may feel temporarily calming. Reducing both is a meaningful lifestyle lever. Finally, reducing isolation by connecting regularly with others, whether in a perimenopause support group or through existing friendships, buffers against anxiety and improves overall wellbeing.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.